11 employees
Oraya Therapeutics develops non-invasive robotically-controlled treatments for inflammatory and neovascular diseases of the eye.
2007
$42M
from 2 investors over 2 rounds
Oraya Therapeutics, Inc. raised $42M on July 20, 2009
Investors: Scale Venture Partners and Domain Associates